Comparative efficacy and safety of single oral doses of sparfloxacin versus ciprofloxacin in the treatment of acute gonococcal urethritis in men

Journal of Antimicrobial Chemotherapy

Volumn 37, Issue SUPPL. A, 1996, Pages 115-122

  Moi, H ^a,f   Morel, P ^b   Gianotti, B ^c   Barlow, D ^d   Phillips, Ian ^d   Jean, C ^e  

^a Dronning Ingrids Hospital   (Greenland)

^b SAINT LOUIS HOSPITAL   (France)

^c UNIVERSITY OF FLORENCE   (Italy)

^d ST THOMAS HOSPITAL   (United Kingdom)

^e Rhone DPC Europe   (France)

^f Postuttak ^*  (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; SPARFLOXACIN;

ABDOMINAL PAIN; ADULT; ARTICLE; BACTERIUM CULTURE; CHLAMYDIA TRACHOMATIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FLATULENCE; GONOCOCCAL URETHRITIS; HUMAN; MALE; MULTICENTER STUDY; NEISSERIA GONORRHOEAE; ORAL DRUG ADMINISTRATION; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; REINFECTION; SEXUAL INTERCOURSE; URETHRITIS;

EID: 0029941582     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/37.suppl_a.115     Document Type: Article

References (27)

1. Aznar, J., Prados, R., Rodriguez-Pichardo, A, Hernandez, I., De Miguel, C. & Perea, E.J. (1986). Comparative clinical efficacy of two different single-dose ciprofloxacin treatments for uncomplicated gonorrhea. Sexually Transmitted Diseases 13, 169-71.
2. Blaisot, B., Mackie, M., Sednaoui, P., Goulet, V. & Catalan, F. (1990). Le gonocoque en France en 1989. Réseau National du Gonocoque (RENAGO), Bulletin Épidémiologique Hebdomadaire no. 52/90.
3. Bogaerts, J., Tello, W. M., Akingeneye, J., Mukantabana, V., Van-Dyck, E. & Piot, P. (1993). Effectiveness of norfloxacin and ofloxacin for treatment of gonorrhoea and decrease of in vitro susceptibility to quinolones over time in Rwanda. Genitourinary Medicine 69, 196-200.
4. Cooper, M. A., Andrews, J. M., Ashby, J. P., Matthews, R. S. & Wise, R. (1990). In-vitro activity of sparfloxacin, a new quinolone antimicrobial agent. Journal of Antimicrobial Chemotherapy 26, 667-76.
5. Genevois, E., Lelouer, V., Vercken, J.-B. & Caillon, R. (1996). Study design, methodology and statistical analyses in the clinical development of sparfloxacin. Journal of Antimicrobial Chemotherapy 37, Suppl. A, 65-72.
6. Gorwitz, R. J., Nakashima, A. K., Moran, J. S. & Knapp, J. S. (1993). Sentinel surveillance for antimicrobial resistance in Neisseria gonorrhoeae - United States, 1988-1991. The Gonococcal Isolate Surveillance Project Study Group. Morbidity and Mortality Weekly Report, Center for Disease Control, Surveillance Summary 42, 29-39.
7. Gransden, W. R., Warren, C. A., Phillips, I., Hodges, M. & Barlow, D. (1990). Decreased susceptibility of Neisseria gonorrhoeae to ciprofloxacin Lancet 335, 51.
8. Hook, E. W., Brady, W. E., Reichart, C. A., Upchurch, D. M., Sherman, L. A. & Wasserheit, J. N. (1989). Determinants of emergence of antibiotic-resistant Neisseria gonorrhoeae. Journal of Infectious Diseases 159, 900-7.
9. Jephcott, A. E. & Turner, A. (1990). Ciprofloxacin resistance in gonococci, Lancet 335, 165.
10. Korting, H. C. & Lukacs, A. (1989). Decrease of antimicrobial susceptibility of gonococci to newer quinolones after repeated exposition to subinhibitory concentrations in vitro. Infection 17, Suppl. 1, S6-10.
11. Lassus, A., Karppinen, L., Ingervo, L., Jeskanen, L., Reitamo, R., Happonen, H. et al. (1989). Ciprofloxacin versus amoxycillin and probenecid in the treatment of uncomplicated gonorrhoea. Scandinavian Journal of Infectious Diseases, Suppl., 60, 58-61.
12. Martin, D. H., Cammarata, C. L. & Grubb, D. (1991). In-vitro activity of sparfioxacin (Cl-978, AT-4140), ofloxacin, doxycycline and tetracycline versus genital tract mycoplasma and Chlamydia trachomatis. European Journal of Microbiology and Infectious Diseases Special Issue, 63-71.
13. National Committee for Clinical Laboratory Standards. (1988). Performance Standards for Antimicrobial Disk Susceptibility Test. Tentative Standard M2-T4. NCCLS, Villanova, PA.
14. O'Mahony, C. & Timmins, D. (1992). Treatment failure using double dose ciprofloxacin in a case of highly resistent gonorrhoea. Genitourinary Medicine 68, 274-5.
15. Orfanos, C. E., Adler, M., Hörnle, R., Stadler, R. & Wagner J. (1989). Spectinomycin-resistente Gonokokken-Infektionen Inder Bundersrepublik Deutschland. Hautartzt 40, 713-7.
16. Phillips, I., Dimian, C., Barlow, D., Moi, H., Stolz, E., Weidner, W. et al. (1996). A comparative study of two different regimens of sparfloxacin versus doxycycline in the treatment of non-gonococcal urethritis in men. Journal of Antimicrobial Chemotherapy 37, Suppl. A, 123-34.
17. Piot, P. & Tezzo, R. (1990). The epidemiology of HIV and other sexually transmitted infections in the developing world. Scandinavian Journal of Infectious Diseases, Suppl. 69, 89-97.
18. Richmond, S. J., Hilton, A. L. & Clarke, S. K. R. (1972). Chlamydial infection. Role of Chlamydia subgroup A in non-gonococcal and post-gonococcal urethritis. British Journal of Venereal Diseases 48, 437-44.
19. Ringertz, S., Rylander, M. & Kronvall, G. (1991). Disk diffusion method for susceptibility testing of Neisseria gonorrhoeae. Journal of Clinical Microbiology 29, 1604-9.
20. Schwarcz, S. K., Zenilman, J. M., Schnell, D., Knapp, J. S., Hook, E. W., Thompson, S. et al. (1990). National surveillance of antimicrobial resistance in Neisseria gonorrhoeae. The Gonococcal Isolate Surveillance project. Journal of American Medical Association 264, 1413-7.
21. Sehgal, S. C. (1990). Epidemiology of male urethritis in Nigeria. Journal of Tropical Medicine and Hygiene 93, 151-2.
22. Shahmanesh, M., Shukla, S. R., Philips, I., Westwood, A. & Thin R. N. (1986). Ciprofloxacin for treating urethral gonorrhoea in men. Genitourinary Medicine 62, 86-7.
23. Tanaka, M., Kumazawa, J., Matsumoto, T. & Kobayashi, I. (1994). High prevalence of Neisseria gonorrhoeae strains with reduced susceptibility to fluoroquinolones in Japan. Genitourinary Medicine 70, 90-3.
24. Thirumoorthy, T. (1991). The epidemiology of sexually transmitted diseases in Southeast Asia and the western Pacific 1990. Seminars in Dermatology 9, 102-4.
25. Walckiers, D., Piot, P., Stroobant, A., Van der Veken, J. & Declercq, E. (1991). Declining trends in some sexually transmitted diseases in Belgium between 1983 and 1989. Genitourinary Medicine 67, 374-7.
26. Wolfson, J. S. & Hooper, D. C. (1989). Bacterial resistance to quinolones: mechanisms and clinical importance. Reviews of Infectious Diseases 11, Suppl. 5., 960-8.
27. WHO (1991). Management of Patients with Sexually Transmitted Diseases. World Health Organization Technical Report Series. 810, p. 85 WHO, Geneva.